Metoprolol Succinate
Product Images NDC 58177-358

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 58177-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ethex Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Metoprolo Su Er Tb 01)

FDA Label Image

Figure (Metoprolo Su Er Tb 02)

This is a table showing results of a study comparing the effectiveness of Metoprolol Succinate Extended-Release Tablets and Placebo for patients with heart failure. The table includes data such as time to first event of hospitalization and total hospitalizations, as well as patient demographics such as sex, race, and preexisting conditions. There are also columns showing relative risk and 95% confidence intervals.*

FDA Label Image

100 mg (100 Tablets Bottle Label)

FDA Label Image

100 mg (1000 Tablets Bottle Label)

Metoprolol SR (Sustained Release) is an oral medication used to treat hypertension, angina pectoris (chest pain), and other heart-related conditions. It can also be used for the prevention of cardiovascular disease. This medication is available in the form of extended-release tablets under the brand name Succin.*

FDA Label Image

100 mg (100 Tablets Blister Pack Label)

FDA Label Image

200 mg (100 Tablets Bottle Label)

FDA Label Image

200 mg (1000 Tablets Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.